AST; Oliver
Patent Applications and Registrations
Patent applications and USPTO patent grants for AST; Oliver.The latest application filed is for "novel immunoconjugates".
Company Profile
19.19.34
- AST; Oliver - Bassersdorf CH
- Ast, Oliver - Dransfeld DE
Patent Activity
| Patent | Date |
|---|---|
| Novel Immunoconjugates App 20220242971 - AST; Oliver ; et al. | 2022-08-04 |
| Immunoconjugates Grant 11,130,822 - Ast , et al. September 28, 2 | 2021-09-28 |
| Bispecific T cell activating antigen binding molecules Grant 11,117,965 - Ast , et al. September 14, 2 | 2021-09-14 |
| Mutant interleukin-2 polypeptides Grant 11,111,312 - Ast , et al. September 7, 2 | 2021-09-07 |
| Method For The Selection Of Antibodies Against Bcma App 20210070873 - VU; Minh Diem ; et al. | 2021-03-11 |
| Method for the selection of antibodies against BCMA Grant 10,851,171 - Vu , et al. December 1, 2 | 2020-12-01 |
| Monoclonal Antibodies Against Bcma App 20200283545 - Vu; Minh Diem ; et al. | 2020-09-10 |
| Bispecific Antibodies Against Cd3epsilon And Ror1 App 20200255521 - Kind Code | 2020-08-13 |
| Bispecific T Cell Activating Antigen Binding Molecules App 20200231673 - AST; Oliver ; et al. | 2020-07-23 |
| Monoclonal antibodies against BCMA Grant 10,683,369 - Vu , et al. | 2020-06-16 |
| Bispecific T cell activating antigen binding molecules Grant 10,611,841 - Ast , et al. | 2020-04-07 |
| Bispecific T cell activating antigen binding molecules Grant 10,611,840 - Ast , et al. | 2020-04-07 |
| Monoclonal Antibodies Against Bcma App 20190352427 - Vu; Minh Diem ; et al. | 2019-11-21 |
| Mutant Interleukin-2 Polypeptides App 20190322765 - Ast; Oliver ; et al. | 2019-10-24 |
| Novel Immunoconjugates App 20190322763 - AST; Oliver ; et al. | 2019-10-24 |
| Novel Immunoconjugates App 20190315883 - AST; Oliver ; et al. | 2019-10-17 |
| Mutant interleukin-2 polypeptides Grant 10,323,098 - Ast , et al. | 2019-06-18 |
| Immunoconjugates Grant 10,316,104 - Ast , et al. | 2019-06-11 |
| Bispecific antibodies against CD3 and BCMA Grant 10,253,104 - Vu , et al. | 2019-04-09 |
| Mutant Interleukin-2 Polypeptides App 20190077881 - Ast; Oliver ; et al. | 2019-03-14 |
| Immunoconjugates Grant 10,202,464 - Ast , et al. Feb | 2019-02-12 |
| Mutant interleukin-2 polypeptides Grant 10,184,009 - Ast , et al. Ja | 2019-01-22 |
| Anti-cd3xrob04 Bispecific T Cell Activating Antigen Binding Molecules App 20180282410 - AST; Oliver ; et al. | 2018-10-04 |
| Bispecific T Cell Activating Antigen Binding Molecules App 20180273643 - AST; Oliver ; et al. | 2018-09-27 |
| Bispecific antibodies against CD3 and BCMA Grant 10,077,315 - Vu , et al. September 18, 2 | 2018-09-18 |
| Method For The Selection Of Antibodies Against Bcma App 20180222991 - VU; Minh Diem ; et al. | 2018-08-09 |
| Bispecific T Cell Activating Antigen Binding Molecules App 20180222980 - AST; Oliver ; et al. | 2018-08-09 |
| Bispecific T Cell Activating Antigen Binding Molecules App 20180222981 - AST; Oliver ; et al. | 2018-08-09 |
| Mutant Interleukin-2 Polypeptides App 20180142037 - AST; Oliver ; et al. | 2018-05-24 |
| Method for the selection of antibodies against BCMA Grant 9,963,513 - Vu , et al. May 8, 2 | 2018-05-08 |
| Bispecific T cell activating antigen binding molecules Grant 9,914,776 - Ast , et al. March 13, 2 | 2018-03-13 |
| Bispecific Antibodies Against Cd3epsilon And Bcma App 20170327579 - VU; MINH DIEM ; et al. | 2017-11-16 |
| Bispecific Antibodies Against Cd3epsilon And Ror1 For Use In The Treatment Of Ovarian Cancer App 20170306044 - VU; MINH DIEM ; et al. | 2017-10-26 |
| Bispecific Antibodies Against Cd3epsilon And Ror1 App 20170306018 - VU; MINH DIEM ; et al. | 2017-10-26 |
| Bispecific Antibodies Against Cd3epsilon And Bcma App 20170306036 - VU; Minh Diem ; et al. | 2017-10-26 |
| Novel Immunoconjugates App 20170088631 - Ast; Oliver ; et al. | 2017-03-30 |
| BISPECIFIC ANTIBODIES AGAINST CD3EPSILON and ROR1 App 20160297881 - VU; Minh Diem ; et al. | 2016-10-13 |
| Immunoconjugates Grant 9,447,159 - Ast , et al. September 20, 2 | 2016-09-20 |
| Novel Immunoconjugates App 20160263240 - Ast; Oliver ; et al. | 2016-09-15 |
| Mutant Interleukin-2 Polypeptides App 20160208017 - Ast; Oliver ; et al. | 2016-07-21 |
| Bispecific T Cell Activating Antigen Binding Molecules App 20160075785 - Ast; Oliver ; et al. | 2016-03-17 |
| Mutant interleukin-2 polypeptides Grant 9,266,938 - Ast , et al. February 23, 2 | 2016-02-23 |
| Bispecific Antibodies Against Cd3 And Bcma App 20150376287 - VU; Minh Diem ; et al. | 2015-12-31 |
| Method For The Selection Of Antibodies Against Bcma App 20150368351 - VU; Minh Diem ; et al. | 2015-12-24 |
| Bispecific T Cell Activating Antigen Binding Molecules App 20130078250 - Ast; Oliver ; et al. | 2013-03-28 |
| Bispecific T Cell Activating Antigen Binding Molecules App 20130078249 - Ast; Oliver ; et al. | 2013-03-28 |
| Novel Immunoconjugates App 20120276125 - Ast; Oliver ; et al. | 2012-11-01 |
| Mutant Interleukin-2 Polypeptides App 20120244112 - Ast; Oliver ; et al. | 2012-09-27 |
| Compositions for transferring active compounds in a cell-specific manner App 20030044961 - Luke, Wolfgang ; et al. | 2003-03-06 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 